|
1
|
Wei KR, Xu Y, Liu J, Zhang WJ and Liang
ZH: Histopathological classification of nasopharyngeal carcinoma
(Review). Asian Pac J Cancer Prev. 12:1141–1147. 2011.
|
|
2
|
Zhen Y, Ye Y, Yu X, Mai C, Zhou Y, Chen Y,
Yang H, Lyu X, Song Y, Wu Q, Fu Q, Zhao M, Hua S, Wang H, Liu Z,
Zhang Y and Fang W: Reduced CTGF expression promotes cell growth,
migration, and invasion in nasopharyngeal carcinoma. PLoS One.
8:e649762013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ho FC, Tham IW, Earnest A, Lee KM and Lu
JJ: Patterns of regional lymph node metastasis of nasopharyngeal
carcinoma: a meta-analysis of clinical evidence. BMC Cancer.
12:982012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jia WH and Qin HD: Non-viral environmental
risk factors for nasopharyngeal carcinoma: a systematic review.
Semin Cancer Biol. 22:117–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Isinger-Ekstrand A, Johansson J, Ohlsson
M, Francis P, Staaf J, Jönsson M, Borg A and Nilbert M: Genetic
profiles of gastroesophageal cancer: combined analysis using
expression array and tiling array - comparative genomic
hybridization. Cancer Genet Cytogenet. 200:120–126. 2010.
View Article : Google Scholar
|
|
6
|
Gottschalk AJ, Timinszky G, Kong SE, Jin
J, Cai Y, Swanson SK, Washburn MP, Florens L, Ladurner AG, Conaway
JW and Conaway RC: Poly(ADP-ribosyl)ation directs recruitment and
activation of an ATP-dependent chromatin remodeler. Proc Natl Acad
Sci USA. 106:13770–13774. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kokavec J, Podskocova J, Zavadil J and
Stopka T: Chromatin remodeling and SWI/SNF2 factors in human
disease. Front Biosci. 13:6126–6134. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma NF, Hu L, Fung JM, Xie D, Zheng BJ,
Chen L, Tang DJ, Fu L, Wu Z, Chen M, Fang Y and Guan XY: Isolation
and characterization of a novel oncogene, amplified in liver cancer
1, within a commonly amplified region at 1q21 in hepatocellular
carcinoma. Hepatology. 47:503–510. 2008.
|
|
9
|
Chen L, Chan TH, Yuan YF, Hu L, Huang J,
Ma S, Wang J, Dong SS, Tang KH, Xie D, Li Y and Guan XY: CHD1L
promotes hepatocellular carcinoma progression and metastasis in
mice and is associated with these processes in human patients. J
Clin Invest. 120:1178–1191. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen L, Yuan YF, Li Y, Chan TH, Zheng BJ,
Huang J and Guan XY: Clinical significance of CHD1L in
hepatocellular carcinoma and therapeutic potentials of
virus-mediated CHD1L depletion. Gut. 60:534–543. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung MS, Lee SH, Lee DH and Chung BH:
Evaluation of the 7th American Joint Committee on cancer TNM
staging system for prostate cancer in point of classification of
bladder neck invasion. Jpn J Clin Oncol. 43:184–188. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheng W, Su Y and Xu F: CHD1L: a novel
oncogene. Mol Cancer. 12:1702013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He WP, Zhou J, Cai MY, Xiao XS, Liao YJ,
Kung HF, Guan XY, Xie D and Yang GF: CHD1L protein is overexpressed
in human ovarian carcinomas and is a novel predictive biomarker for
patients survival. BMC Cancer. 12:4372012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Chen L, Chan TH, Liu M, Kong KL, Qiu
JL, Li Y, Yuan YF and Guan XY: SPOCK1 is regulated by CHD1L and
blocks apoptosis and promotes HCC cell invasiveness and metastasis
in mice. Gastroenterology. 144:179–191.e4. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ji X, Li J, Zhu L, Cai J, Zhang J, Qu Y,
Zhang H, Liu B, Zhao R and Zhu Z: CHD1L promotes tumor progression
and predicts survival in colorectal carcinoma. J Surg Res.
185:84–91. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tian F, Xu F, Zhang ZY, Ge JP, Wei ZF, Xu
XF and Cheng W: Expression of CHD1L in bladder cancer and its
influence on prognosis and survival. Tumour Biol. 34:3687–3690.
2013. View Article : Google Scholar : PubMed/NCBI
|
